MODUR VIJAY 4
4 · Eloxx Pharmaceuticals, Inc. · Filed Dec 3, 2021
Insider Transaction Report
Form 4
MODUR VIJAY
HEAD OF R&D
Transactions
- Tax Payment
Common Stock
2021-12-01$0.72/sh−64,373$46,349→ 154,953 total - Exercise/Conversion
Restricted Stock Units
2021-12-01−219,326→ 0 total→ Common Stock (219,326 underlying) - Exercise/Conversion
Common Stock
2021-12-01+219,326→ 219,326 total
Footnotes (3)
- [F1]The restricted stock units issued to the reporting person on April 1, 2021 have fully vested and settled for shares of the Issuer's common stock.
- [F2]Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.
- [F3]The restricted stock units were issued pursuant to the Issuer's 2018 Equity Incentive Plan.